9-28677726-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001258282.3(LINGO2):c.-394-7446T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0971 in 152,162 control chromosomes in the GnomAD database, including 934 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.097 ( 934 hom., cov: 31)
Consequence
LINGO2
NM_001258282.3 intron
NM_001258282.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.407
Publications
3 publications found
Genes affected
LINGO2 (HGNC:21207): (leucine rich repeat and Ig domain containing 2) Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LINGO2 | NM_001258282.3 | c.-394-7446T>A | intron_variant | Intron 2 of 6 | ENST00000698399.1 | NP_001245211.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LINGO2 | ENST00000698399.1 | c.-394-7446T>A | intron_variant | Intron 2 of 6 | NM_001258282.3 | ENSP00000513694.1 | ||||
| LINGO2 | ENST00000698401.1 | c.-764-7446T>A | intron_variant | Intron 2 of 7 | ENSP00000513696.1 | |||||
| LINGO2 | ENST00000698402.1 | c.-549-7446T>A | intron_variant | Intron 2 of 7 | ENSP00000513697.1 | |||||
| LINGO2 | ENST00000698404.1 | c.-505-7446T>A | intron_variant | Intron 2 of 8 | ENSP00000513699.1 |
Frequencies
GnomAD3 genomes AF: 0.0972 AC: 14777AN: 152046Hom.: 935 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14777
AN:
152046
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0971 AC: 14771AN: 152162Hom.: 934 Cov.: 31 AF XY: 0.101 AC XY: 7524AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
14771
AN:
152162
Hom.:
Cov.:
31
AF XY:
AC XY:
7524
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
1313
AN:
41542
American (AMR)
AF:
AC:
1410
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
147
AN:
3470
East Asian (EAS)
AF:
AC:
1010
AN:
5162
South Asian (SAS)
AF:
AC:
673
AN:
4822
European-Finnish (FIN)
AF:
AC:
1803
AN:
10596
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8181
AN:
67974
Other (OTH)
AF:
AC:
178
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
657
1313
1970
2626
3283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
489
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.